July 28, 2014

The Food and Drug Administration on Monday expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.

July 28, 2014

The Food and Drug Administration has accepted a license application by Sandoz, Novartis' generics company, for a potential generic biologic drug, the company announced Monday.

July 25, 2014

AmerisourceBergen reported increased revenue of $30.3 billion for third-quarter 2014 ended June 30, a 39% increase.

July 25, 2014

The National Association of Specialty Pharmacy  and the Specialty Pharmacy Association of America announced the merger of the two organizations, creating the largest professional and trade association focused on the unique needs in specialty pharmacy. 



July 24, 2014

Abbott, the makers of Similac, studied the diets of more than 80 lactating women to assess how their nutritional intake compared to dietary recommendations. In the study, only 1-of-10 breastfeeding moms on average got 100% of the desired levels for DHA, lutein and vitamin E from their diet.

July 24, 2014

The Consumer Healthcare Products Association celebrated the first International Self-Care Day event in the United States.

July 24, 2014

GlaxoSmithKline announced that the Food and Drug Administration has approved Flonase Allergy Relief as an over-the-counter treatment.

July 24, 2014

The Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), a long-acting opioid analgesic.

July 24, 2014

Onco360, an independent oncology pharmacy and clinical support services company, announced that it has been selected to be part of the highly limited specialty pharmacy network of Zydelig tablets.

July 23, 2014

Health on the National Mall, co-sponsored by Cardinal Health and the National Community Pharmacists Association, showcased the expanding role pharmacists are playing in improving patient care.

July 23, 2014

Inergetics, a developer of nutritional supplements, announced that the company will be presenting Martha Stewart Essentials, a line of whole food-based vitamin supplements developed in tandem with Martha Stewart herself at Cardinal Health's Retail Business Conference.

July 23, 2014

Mylan on Wednesday announced that U.S. District Court for the district of New Jersey granted a temporary restraining order against Apotex Inc. and Apotex Corp. relating to Paroxetine CR.

July 23, 2014

The first batch of vaccines for the upcoming flu season is on its way to pharmacies, hospitals and doctors offices.

July 23, 2014

The Food and Drug Administration on Wednesday announced approval for Zydelig (idelalisib) to treat patients with chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.

July 22, 2014

The Food and Drug Administration has granted tentative approval to Teva Pharmaceutical for abacavir sulfate and lamivudine tablets, according to agency records.

July 22, 2014

The Little Clinic announced a number of new store openings, including its first clinic locations in Virginia.

July 22, 2014

Walgreens on Tuesday announced the new Balance Rewards for healthy choices initiatives, which is aimed at helping participants modify behavior risk factors associated with the nation's most pressing public health issues.

July 22, 2014

Walgreens announced the official opening of a new pharmacy at Children's National Health System.

July 21, 2014

AbbVie has finalized a deal for Dublin-based specialty pharmaceuticals company Shire for $54.7 billion.

July 21, 2014

Illinois Gov. Pat Quinn signed a bill Monday that opens up medical marijuana to treat symptoms of epilepsy in adults and children.

July 21, 2014

Innocutis on Monday announced the introduction of Sitavig (acyclovir) 50-mg buccal tablet into North American markets.

July 21, 2014

Commentary published online Monday addresses the controversy surrounding the high costs of new Hepatitis C virus treatments and implications for the growing specialty pharmacy market. 

 

July 21, 2014

The new KL1Plus double counts the tablets it dispenses and can then store the count data for up to 10 years.

July 21, 2014

The Food and Drug Administration’s Center for Drug Evaluation and Research is providing an update to key leadership positions within the Office of Generic Drugs, the agency announced.